Health and Fitness

FDA Approves Otezla to Treat Psoriatic Arthritis

by on

More in Health and Fitness:

Washington, DC—(ENEWSPF)—March 21, 2014. The U.S. Food and Drug Administration today approved Otezla (apremilast) to treat adults with active psoriatic arthritis (PsA).

Proud member of LION Publishers

Most read stories this week

Take a Survey

ARCHIVES